- Home
- AGAE vs NTRB Comparison
AGAE vs NTRB Comparison
Compare AGAE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- NTRB
- Stock Information
- Founded
- AGAE 2017
- NTRB 2016
- Country
- AGAE United States
- NTRB United States
- Employees
- AGAE N/A
- NTRB N/A
- Industry
- AGAE Cable & Other Pay Television Services
- NTRB Industrial Specialties
- Sector
- AGAE Telecommunications
- NTRB Health Care
- Exchange
- AGAE Nasdaq
- NTRB Nasdaq
- Market Cap
- AGAE 37.0M
- NTRB 77.9M
- IPO Year
- AGAE N/A
- NTRB N/A
- Fundamental
- Price
- AGAE $0.73
- NTRB $4.08
- Analyst Decision
- AGAE
- NTRB
- Analyst Count
- AGAE 0
- NTRB 0
- Target Price
- AGAE N/A
- NTRB N/A
- AVG Volume (30 Days)
- AGAE 24.9K
- NTRB 30.2K
- Earning Date
- AGAE 11-14-2024
- NTRB 12-04-2024
- Dividend Yield
- AGAE N/A
- NTRB N/A
- EPS Growth
- AGAE N/A
- NTRB N/A
- EPS
- AGAE N/A
- NTRB N/A
- Revenue
- AGAE $9,256,023.00
- NTRB $2,021,771.00
- Revenue This Year
- AGAE N/A
- NTRB N/A
- Revenue Next Year
- AGAE N/A
- NTRB N/A
- P/E Ratio
- AGAE N/A
- NTRB N/A
- Revenue Growth
- AGAE 36.15
- NTRB N/A
- 52 Week Low
- AGAE $0.61
- NTRB $2.22
- 52 Week High
- AGAE $1.57
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- AGAE 23.43
- NTRB 40.82
- Support Level
- AGAE $0.70
- NTRB $3.87
- Resistance Level
- AGAE $0.92
- NTRB $4.80
- Average True Range (ATR)
- AGAE 0.06
- NTRB 0.51
- MACD
- AGAE -0.01
- NTRB 0.04
- Stochastic Oscillator
- AGAE 8.57
- NTRB 21.21
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.